BEdtime Sublingual TNX-102 SL as Fibromyalgia Intervention Therapy (BESTFIT)

NCT01903265 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

205

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Fibromyalgia

Interventions

DRUG: TNX-102 SL 2.8mg
DRUG: Placebo

Sponsor

Tonix Pharmaceuticals, Inc.